CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer. - Wikidata - awgldk - TriplyDB

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

http://www.wikidata.org/entity/Q54352682

about

Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas Role of CHD5 in human cancers: 10 years later CHD5 is required for spermiogenesis and chromatin condensation Chd5 requires PHD-mediated histone 3 binding for tumor suppression Multivalent recognition of histone tails by the PHD fingers of CHD5 Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes Therapeutic targets for neuroblastomas.The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.Mechanisms of CHD5 Inactivation in neuroblastomas.Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.Silencing of CHD5 gene by promoter methylation in leukemia.Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.Chromatin regulators with tumor suppressor properties and their alterations in human cancers.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5.The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.Decreased expression of chromodomain helicase DNA-binding protein 5 is an unfavorable prognostic marker in patients with primary gallbladder carcinoma.A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk.

P2860

Q26751724-A73056EB-5564-42B6-9ACE-94319198DF27 Q27006929-30D16E7E-7642-4186-8070-8C2045E04E8F Q28510857-FE7DC336-B9F5-4408-85D8-EA0861711680 Q28593132-4F6009D0-A26D-42E8-A264-1B4C19F35B93 Q34352597-D44F257F-7BF3-4A57-A936-BD90C0E981B0 Q34520690-FF510E4C-040D-4AD6-9EBC-8E637DB97650 Q34560877-6339C053-ADA6-4A33-86D3-A8D93BF86DD3 Q35806478-3D366E7A-9ABA-4824-9972-DEFED818A4FA Q35836491-05A8C7DB-64D0-4A9D-B0F7-58E574B5A77A Q35923727-CDAB25D8-FE01-43C9-A255-B0129915C217 Q37225359-A747AC89-1DA4-420A-AF39-B66BF868395F Q37472949-9E0CA353-7A4C-4B91-A16A-0F05424A986B Q37626242-EDFF5F75-D4E8-4033-95A1-DEB0BF32C12E Q37735355-0CFE7C69-EC4F-4306-931A-7A2ACFDD8786 Q38058125-61A1E553-54C4-41E0-A007-74A292AE2108 Q38432883-70FCD18D-4DE0-4FB1-BB66-ED9A72994C6E Q38752467-8672DA98-D27A-4E71-B072-2B9064F9A60A Q41786481-3D9D5D80-BDFD-4B3A-A591-14F039D3B1A3 Q43989091-B5F633DE-C22E-4A8E-91B5-E81D9934285D Q45921428-034EF537-4B3D-4799-9DA2-3A2FC102026E Q55424161-46DD9DFC-F58C-4B1B-B2F4-B895BFCCA0BA

P2860

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

http://www.wikidata.org/entity/Q54352682

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@en

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@nl

type

label

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@en

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@nl

prefLabel

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@en

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@nl

P1433

Q54352682-179E0203-B766-4713-B310-3350964DCFFF

P1476

Q54352682-EDB32DF5-4844-4147-8D49-C849EF0C11A3

P2093

Q54352682-0463868A-55FD-419B-8B87-F3FF536C197E

Q54352682-04801670-76E9-4726-8ABE-D91F93FDEFD0

Q54352682-055F7D38-7A94-4767-9E5E-EBF28525DA0C

Q54352682-0C647C37-0C5D-4EF6-BCC7-FA264CD8E6F5

Q54352682-3996A705-6992-4025-93E6-CE6E360DE06C

Q54352682-4FA6F33B-FE45-4021-8C94-24FF88C3ADCE

Q54352682-68A0413C-58B7-4D91-915E-125FAC537C19

Q54352682-878B2502-2F41-42A4-B8BB-BECDD4A76A65

Q54352682-A58ADF0A-F794-4EF9-82B0-88310B8FE4DB

Q54352682-C9E9D00C-5BB6-4FC9-9D2B-E56861BDE97D

P2860

Q54352682-01192120-58A7-457D-8858-429E9D85667C

Q54352682-0AF8B9A9-B376-4390-8669-63CA91511B1B

Q54352682-B591B6E9-465D-46B0-8C70-BED1772F2BC8

Q54352682-E9E3292B-0685-4F9F-8006-F6B2ECE8026E

P304

Q54352682-D4DE6081-370C-45C0-B252-7674CD688A9B

P31

Q54352682-241E58DD-F936-4A7D-A123-7BDA9644589A

P356

Q54352682-FEFD7CDF-724F-4972-B9BD-6C5BB5CF6A6C

P433

Q54352682-AD1301F0-F160-4F6E-AF45-255C2DAD52B8

P478

Q54352682-9266A2F4-8F88-42AA-B4FF-B38ACC08807E

P577

Q54352682-A33824C9-F3D4-4727-8D1B-B790E157B4CB

P698

Q54352682-28D15B15-D79C-440C-B875-7B95A65619EC

P921

Q54352682-F2EF6874-F6C3-487D-867A-28C38662062A

P356

P1433

Gynecologic and Obstetric Investigation

P1476

CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.

@en

P2093

Coral W S Lee

http://www.w3.org/2001/XMLSchema#string

Loucia K Y Chan

http://www.w3.org/2001/XMLSchema#string

M Y Yu

http://www.w3.org/2001/XMLSchema#string

Nelson S S Siu

http://www.w3.org/2001/XMLSchema#string

Raymond R Y Wong

http://www.w3.org/2001/XMLSchema#string

S F Yim

http://www.w3.org/2001/XMLSchema#string

Sophia N C Lee

http://www.w3.org/2001/XMLSchema#string

Stephen S C Chim

http://www.w3.org/2001/XMLSchema#string

T H Cheung

http://www.w3.org/2001/XMLSchema#string

Teresa P T Tsang

http://www.w3.org/2001/XMLSchema#string

P2860

CHD5 is a tumor suppressor at human 1p36

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Multicolor spectral karyotyping of serous ovarian adenocarcinoma.

P304

203-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000323883

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21860208

http://www.w3.org/2001/XMLSchema#string

P921